Reduced LARGE expression levels were found also in the single dysferlinopathy (P13) and calpainopathy (P21) patients compared with age-matched healthy controls, with more severe reduction in LARGE and more severe dystrophic features in the case with dysferlin deficiency. This evidence concerns the gene LARGE1 and neuromuscular disease caused by qualitative or quantitative defects of dysferlin.